Abstract levels during HD. Hence, in addition to the known impairment of reverse cholesterol transport, the reducIntroduction. Cardiovascular diseases represent the major cause of mortality in haemodialysis (HD) tion of HDL protective capacity against oxidative stress could be involved in the development of patients. Oxidized low-density lipoprotein (Ox-LDL) is a major cardiovascular risk factor, implicated in HD-induced atherosclerosis. atherosclerotic plaque formation. It has been suggested Keywords: high-density lipoprotein; lipid peroxidation; that high-density lipoprotein (HD) has the capacity to low-density lipoprotein reduce the oxidative modifications of LDL. The aim of this study is to analyse the protective effects of HDL in HD patients. [5, 6 ] . In addition to these quantitative altera-V max.
evaluated in 12 patients with chronic renal failure (mean age 61.0±12.8 years) and compared to 25 Cardiovascular diseases are recognized as the major healthy subjects (mean age 57.3±19.2 years). LDL cause of mortality and morbidity in haemodialysis were incubated in oxygen-saturated PBS, LDL oxida-(HD) patients [1] [2] [3] . Several atherogenic risk factors tion was initiated by Cu (II ) in the presence and including dyslipidaemia and oxidative stress have been absence of HDL and assessed by measuring the identified. Chronic renal failure-induced dyslipidaemia absorbance (abs) increase at 234 nm due to conjugated substantially contributes to the vascular complications diene formation. Duration of lag time, maximum velobserved in this population [4] . Lipid abnormalities ocity (V max.
) of lipid peroxidation, oxidation slope and are characterized by a moderate hypertriglyceridaemia half-time of maximum diene formation (TD) were and normal total cholesterol. Profound alterations of obtained by kinetic modelling analysis.
lipoprotein profile and lipoprotein composition are Results. HDL (1.06±0.31 vs 1.23±0.39 mmol/l ) and frequently encountered including elevated apolipoApo AI (1.17±0.39 vs 1.49±0.20 g/l ) levels were protein B (Apo B)-containing triglyceride-rich lipoprodecreased in HD patients. In the absence of HDL, teins (very low-density lipoprotein ( VLDL) and LDL obtained from HD patients showed an enhanced intermediate density lipoprotein IDL) low levels of susceptibility to oxidation in vitro as demonstrated plasma apolipoprotein AI (Apo AI ) and high-density by the significant decrease in lag time (54.5±22.2 lipoprotein (HDL) affecting the reverse cholesterol vs 79.4±37.8 min) and a significant increase in transport [5, 6 ] . In addition to these quantitative altera-V max.
(0.026±0.006 vs 0.017±0.005 abs/min). In all tions, an increase in small, dense low-density lipoprocases, HDL (from 0.1 to 2 mM ) prevented LDL oxidatein (LDL) subfractions has been recently been found tion in vitro; however, this effect was significantly [7, 8] . In non-uraemic patients, these small dense LDL, reduced in HD patients: increase in lag time 54.2% vs which are derived from triglyceride-rich lipoproteins, 150.4% in HD vs controls; increase in TD 52.2% vs present an increased susceptibility to oxidation [9] . 124.6% in HD vs controls; decrease in V max . 13.5% vs An oxidative stress due to overproduction of reactive 38.5% in HD vs controls.
oxygen species (ROS ) by activated monocytes and Conclusions. These results suggest that qualitative impairment in antioxidant defence mechanisms [10] [11] [12] abnormalities such as an impairment of HDL-associhas been observed in HD patients [13, 14] and may ated enzymes are associated with a decrease of HDL contribute to the accelerated HD-induced atherogenesis by oxidatively modified-proteins and lipids. Indeed, Correspondence and offprint requests to: Marion Morena, Department vulnerability of proteins to ROS results in the oxidation lipidaemic subjects (mean age 57.3±19.2 years), free of lipidprotein products (AOPP) [15, 16 ] . Such compounds lowering drugs or antioxidant supplementation, were have been recently shown to act as mediators of included in this study after giving informed consent.
oxidative stress and monocyte activation [17] .
Characteristics of the subjects are summarized in Table 1 .
Furthermore, it is interesting to note that such phen-All end-stage renal disease patients were treated by on-line omena also pre-exists to dialysis treatment [18, 19] , post-dilutional haemodiafiltration (Fresenius 2008, Bad occurring early in the course of the chronic renal Homburg, Germany) using 1.8 m2 polysulphone membrane failure and growing with its progression to end-stage haemodiafilter (HF80, Fresenius) at a mean blood flow rate renal disease [20] . Oxidized LDL also plays a major of 350±10 ml/min, a mean dialysate flow rate of 600 ml/min; role in the development and progression of athero-ultrafiltration rate was adapted to the extracellular volume patients' needs. Ultrapure dialysate was used in all cases; the sclerotic lesions [21, 22] . In addition to its inducing infusate was produced from the dialysate by 'cold sterilizaendothelial dysfunction, oxidized LDL exhibits prointion' process based on a two-step ultrafiltration [34] data are reported as normal in some studies [25] [26] [27] by immunonephelemetric assay using a Behring or increased in others [24, 28] .
Nephelemeter BN 100 (Behring, Marburg, Germany).
Recently, HDL have also been demonstrated to
Plasma vitamin E was determined using HPLC procedure potentially reduce oxidative modifications of LDL [34] . [29, 30] . The prevention of lipoperoxide generation during copper-induced LDL oxidation by HDL could Human plasma LDL and HDL preparation be due to their enzyme content, such as paraoxonase [29] which has been recently reported to be decreased LDL and HDL were prepared by sequential ultracentrifuin uraemic patients [31] [32] [33] . Clearly, HD-induced LDL gation from plasma [35] . The plasma density was adjusted oxidative modification is a multifactorial process to 1. 
Subjects and methods
The Apo B and Apo AI content of LDL and HDL respectively was measured by immunonephelemetric method using a Behring Nephelemeter BN 100 (Behring, Marburg,
Patients
Germany). Aliquots of 1 ml of LDL and 500 ml of HDL were stored at −80°C in 0.6% sucrose until use [36 ] . Twelve chronic HD patients (mean age 61.0±12.8 years) on renal replacement therapy for at least 1 year and 25 normo-Preliminary data have confirmed that, in our experimental Table 3 . Lipid composition of LDL and HDL in controls and HD Table 2 . Plasma lipid profile of controls and HD patients. TG and TC levels were measured by routine enzymatic methods. HDL patients. LDL and HDL were prepared by sequential ultracentrifugation from plasma. The Apo B and Apo AI content of LDL and concentrations were obtained from plasma after precipitation of Apo B-containing lipoproteins by magnesium phosphotungstate. HDL respectively was measured by immunonephelemetric method using a Behring Nephelemeter BN 100. TG and TC levels were Plasma Apo AI and Apo B were analysed by immunonephelemetric assay using a Behring Nephelemeter BN 100. 
Ex vivo LDL oxidation in presence or absence of HDL
In order to remove EDTA added during the isolation procedby measuring the increase in absorbance (abs) at 234 nm due ure, LDL and HDL were dialysed thrice for 24 h against a to the conjugated diene formation. Absorbance was automat-PBS-DTPA buffer (pH 7.4) at 4°C in the dark under conically recorded at 4-min intervals with a spectrophotometer tinual agitation.
Uvikon 930 ( Kontron Instruments, Montigny le Bretonneux, EDTA free-LDL (0.1 mM Apo B) were incubated in France). Copper-induced oxidation curves were classically oxygen-saturated PBS (37°C, pH 7.4). LDL oxidation was characterized by three different phases: a lag phase corresinduced with copper (Cu(II )) (CuCl 2 : 5 mM ) in the presence ponding to the consumption of protective endogenous antioxof increasing concentrations of HDL obtained from the same idants, a propagation phase corresponding to the radicalsubject (0; 0.1; 0.5; 0.75; 1; 2 mM Apo AI ).
propagated chain reaction, and a decomposition phase [36 ] . The absorption data were collected in a personal computer and slope of the propagation phase were then determined according to a kinetic modelling (Excel 5, Microsoft) [38] .
Continuous measurement of the conjugated diene

Presentation of results and statistical analysis
Results were expressed as mean values±standard error. Differences between controls and HD patients were analysed by a Student's t test. Values were considered statistically significant when P<0.05.
Results
Plasma lipid profile
Plasma lipid profile of controls and HD patients is reported in Table 2 . There is a tendency to higher triglyceride levels and lower HDL-cholesterol in HD patients when compared to control subjects, but the difference is not statistically significant, while no difference in the concentration of Apo B is observed. In addition, Apo AI level is significantly decreased in this same population.
Lipoprotein characteristics
Lipid composition of LDL and HDL is summarized in Table 3 . Triglyceride load in LDL and HDL is higher in HD patients as shown by the significant increase in TG/Apo B and TG/Apo AI ratio respectively.
Enhanced susceptibility of LDL against copper-induced oxidation in HD patients
The kinetic parameters of LDL peroxidation, reported peroxidation in control subjects (>50%). In all cases, HDL prevents LDL against copper-induced oxidation; Protective effects of HDL against LDL oxidation are however, this effect is significantly reduced in HD impaired in HD patients patients: decrease in V max. , 13.5 in HD vs 38.5% in controls ( Figure 3A) , increase in lag time, 54.2% in As shown in Figure 2A , HDL from healthy volunteers HD vs 150.4% in controls ( Figure 3B) ; increase in TD protect LDL against copper-induced oxidation in a 52.2% in HD vs 124.6% in controls. dose-dependent way (0.1-2 mM ). This effect is sensitively observed from 0.5 mM in HDL and leads to a total inhibition at the dose of 2 mM. The protective Discussion effect of HDL against LDL oxidation observed in the control group is reduced in HD patients ( Figure 2B ). This protective effect of HDL virtually disappears in Our study confirms that HD patients are exposed to several atherogenic factors resulting from quantitative some patients.
In order to quantify the protective effect, results are and functional lipid abnormalities including triglyceride-rich lipoparticles, increased susceptibility to LDL expressed as relative variations between isolated LDL oxidation and finally impairment of HDL protective rather than in a defect of vitamin E LDL loading [44] .
These findings are in total agreement with data from effects.
High triglyceride concentration is the main lipid Maggi et al.
[24] which showed that uraemic LDL appeared more susceptible to ex vivo and in vivo abnormality observed in HD patients. This hypertriglyceridaemia results from a reduced lipolysis of TG-rich oxidation (as demonstrated by a higher anti-oxidized LDL antibody/oxidized LDL ratio) while vitamin E VLDL [39, 40] that leads to the accumulation of partially metabolized 'remnant' lipoproteins ( IDL and content of LDL did not differ between the two groups.
Thus, lipid abnormalities including hypertriglyceridae-TG-rich LDL). This lipoprotein catabolism impairment is usually associated with reduced levels of HDL mia, presence of small, dense LDL and enhanced LDL susceptibility to oxidation contribute synergistically to [41] affecting reverse cholesterol transport [6 ] . It is now well known that such defect in atherogenic lipo-the atherogenic profile of HD patients.
Several arguments have suggested a protective role proteins catabolism may predispose to the formation of small, dense LDL particles [42, 43] which appeared of HDL against LDL oxidative modifications. Klimov et al. [45] have reported a protective effect of HDL to be more sensitive to ex vivo oxidation. Consequently, a lipid profile containing predominantly small, dense dependent on incubation time and HDL concentration.
In the present work, this protective and dose-dependent lipoproteins bears a higher risk of coronary artery disease in non-uraemic populations [9, 42] . The pres-action of HDL against LDL oxidability by transition metals was also observed in normal subjects. However, ence of higher content of TG in LDL obtained from HD patients is in agreement with the occurrence of the lack of HDL effect in preventing conjugated diene formation observed in HD patients suggests that HDL small, dense LDL subfraction in end-stage renal failure as recently reported by O'Neal et al. [8] and Rajman are both quantitatively modified and functionally impaired in HD patients. Several enzymes such as et al. [42] . Despite the occurrence of small, dense LDL subfraction, data concerning oxidability of LDL in lecithin cholesterol acyltransferase (LCAT ), protease, phospholipase, platelet-activating factor acetylhy-HD patients remained still a subject of debate. Sutherland et al. [25] have reported no difference in drolase, and paraoxonase are associated in the HDL lipoprotein complex [46 ] . Mackness et al. demonlag time and a lower maximal oxidation rate, lower concentrations of conjugated dienes being formed in strated that HDL-associated paraoxonase, a component of HDL, might contribute to its protective action HD patients compared with healthy controls. However, these parameters could be influenced by the LDL against LDL oxidation [47] and prevent accumulation of lipoperoxides in LDL [29] . Interestingly, reduced content in polyunsaturated fatty acids. Similarly, Loughrey et al. [26 ] and Westhuysen et al.
[27] did serum paraoxonase activity was also reported in a population with high risk of coronary heart disease not observe any modification of LDL susceptibility to ex vivo oxidation in HD patients. In contrast, our such as diabetes and hereditary hypercholesterolaemia [48] . Recent reports strongly support an impairment study shows an enhanced susceptibility of LDL to copper-induced oxidation in HD patients. Indeed, the of paraoxonase activity [6, [31] [32] [33] but not of plateletactivating factor acetylhydrolase activity [6 ] in HDL lag time and the TD are significantly decreased in this population. Similarly, the V max. and the slope of oxida-of HD patients. Accordingly, the absence of protective activity of HDL against LDL oxidation might be tion are significantly increased. In the absence of reduced vitamin E levels in plasma obtained from HD related to the impairment of HDL-associated enzymes and especially paraoxonase. This hypothesis deserves patients, the weaker resistance to copper oxidation could be due to the occurrence of small, dense LDL further study.
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In conclusion, this study shows a decreased HDL Descamps-Latscha B. Advanced oxidation protein products as antioxidant capacity of HD patients that may contriba novel molecular basis of oxidative stress in uraemia. Nephrol ute to the accelerated development of atherosclerosis 
